STOCK TITAN

XTL Biopharmaceuticals Ltd. American (XTLB) Debt by Year

XTLB

XTL Biopharmaceuticals Ltd. American held $76K in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters XTL Biopharmaceuticals Ltd. American has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $76K
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

XTLB Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Long-Term DebtN/A$138KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$76K-79.5%$371K-73.5%$1.4M-33.1%$2.1M-29.5%$3.0M-18.2%$3.6M-18.5%$4.5M+36.9%$3.3M-1.0%$3.3M+62.9%$2.0M-47.1%$3.8M

XTLB Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-KQ1'2510-KQ2'2410-KQ2'2310-KQ4'2210-KQ2'2210-KQ4'2110-KQ2'2110-KQ4'2010-KQ2'2010-KQ2'1910-KQ2'1810-K
Long-Term Debt$138KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$371K-73.5%N/A$1.4M-33.1%$2.1M-29.5%$2.3M-19.6%$3.0M-18.2%$2.9M-27.5%$3.6M-18.5%$4.0M$4.5M+36.9%$3.3M-1.0%$3.3M+62.9%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More XTL Biopharmaceuticals Ltd. American financials

Frequently Asked Questions

What was XTL Biopharmaceuticals Ltd. American's long-term debt in fiscal year 2025?

XTL Biopharmaceuticals Ltd. American held $76K in cash and equivalents at the end of fiscal year 2025, and long-term debt is not reported for that period.

What was XTL Biopharmaceuticals Ltd. American's long-term debt in the most recent quarter?

XTL Biopharmaceuticals Ltd. American (XTLB) reported $138K in long-term debt in Q2 2025.

What does long-term debt mean on a financial statement?

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what XTL Biopharmaceuticals Ltd. American (XTLB) reported on that line in every period on record.